BIO
HealthcareBio-Rad Laboratories, Inc.
$262.87+1.05 (+0.40%)
Prev Close
$261.82
Open
$265.20
High
$270.00
Low
$261.38
Volume
101.5K
Market Cap
$7.26B
P/E
7.05
Div Yield
—
Over the past 12 months, insider activity at Bio-Rad Laboratories, Inc. (BIO) has been exclusively selling, with 0 insider purchases totaling $0.00 and 18 insider sales totaling $2.98M. The most recent insider transaction was by BARRY JAMES (EVP, President, LSG), who sold $214.3K worth of shares on Nov 6, 2025. Bio-Rad Laboratories, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $7.26B.
Buys (12M)
0
$0.00
Sells (12M)
18
$2.98M
Net Activity
Net Seller
$2.98M
Active Insiders
9
last 12 mo
BIO Price Chart
BIO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 6, 2025↗ | BARRY JAMES | EVP, President, LSG | Sell | 700 | $306.13 | $214.3K | 0 |
| Oct 24, 2025↗ | DiVincenzo Jonathan P. | President & COO | Sell | 950 | $339.75 | $322.8K | 0 |
| Oct 20, 2025↗ | EVRAN SEDAT | EVP, Global Supply Chain | Sell | 335 | $321.90 | $107.8K | 0 |
| Sep 5, 2025↗ | Allison Schwartz | Director | Sell | 33 | $295.43 | $9.7K | 0 |
| Sep 5, 2025↗ | BARRY JAMES | EVP, President, LSG | Sell | 378 | $295.43 | $111.7K | 0 |
| Sep 5, 2025↗ | COREY COLLEEN | EVP, Global Human Resources | Sell | 209 | $295.43 | $61.7K | 0 |
| Sep 5, 2025↗ | ENGELHARDT EVA ANETTE | EVP, President, CDG | Sell | 413 | $295.43 | $122.0K | 0 |
| Sep 5, 2025↗ | ENLOE COURTNEY C | EVP, General Counsel & Sec | Sell | 275 | $295.43 | $81.2K | 0 |
| Sep 5, 2025↗ | EVRAN SEDAT | EVP, Global Supply Chain | Sell | 277 | $295.43 | $81.8K | 0 |
| Sep 5, 2025↗ | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | Sell | 550 | $295.43 | $162.5K | 0 |
| Sep 5, 2025↗ | SCHWARTZ NORMAN D | Chairman & CEO | Sell | 1,528 | $295.43 | $451.4K | 0 |
| Sep 1, 2025↗ | Allison Schwartz | Director | Sell | 55 | $297.88 | $16.4K | 0 |
| Sep 1, 2025↗ | BARRY JAMES | EVP, President, LSG | Sell | 217 | $297.88 | $64.6K | 0 |
| Sep 1, 2025↗ | COREY COLLEEN | EVP, Global Human Resources | Sell | 398 | $297.88 | $118.6K | 0 |
| Sep 1, 2025↗ | SCHWARTZ NORMAN D | Chairman & CEO | Sell | 3,084 | $297.88 | $918.7K | 0 |
| Jul 25, 2025↗ | ENGELHARDT EVA ANETTE | EVP, President, CDG | Sell | 88 | $264.19 | $23.2K | 0 |
| Apr 24, 2025↗ | ENLOE COURTNEY C | EVP, General Counsel & Sec | Sell | 67 | $249.74 | $16.7K | 0 |
| Apr 24, 2025↗ | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | Sell | 386 | $249.74 | $96.4K | 0 |
| Mar 14, 2025↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 3,000 | $247.06 | $741.2K | 0 |
| Oct 20, 2024↗ | EVRAN SEDAT | EVP, Global Supply Chain | Sell | 335 | $346.37 | $116.0K | 0 |
| Sep 6, 2024↗ | Last Andrew J. | EVP, Chief Operating Officer | Sell | 3,000 | $329.94 | $989.8K | 0 |
| Sep 1, 2024↗ | Allison Schwartz | Director | Sell | 118 | $336.63 | $39.7K | 0 |
| Sep 1, 2024↗ | BARRY JAMES | EVP, President, LSG | Sell | 1,012 | $332.89 | $336.9K | 0 |
| Sep 1, 2024↗ | COREY COLLEEN | EVP, Global Human Resources | Sell | 700 | $336.56 | $235.6K | 0 |
| Sep 1, 2024↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 1,069 | $336.52 | $359.7K | 0 |
| Sep 1, 2024↗ | Last Andrew J. | EVP, Chief Operating Officer | Sell | 1,854 | $337.32 | $625.4K | 0 |
| Sep 1, 2024↗ | SCHWARTZ NORMAN D | Chairman, President, and CEO | Sell | 5,159 | $336.60 | $1.74M | 0 |
| Jun 13, 2024↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 369 | $281.91 | $104.0K | 0 |
| Apr 29, 2024↗ | Last Andrew J. | EVP, Chief Operating Officer | Sell | 357 | $277.11 | $98.9K | 0 |
| Feb 28, 2024↗ | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sell | 2,500 | $330.55 | $826.4K | 0 |
| Feb 27, 2024↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 3,000 | $336.00 | $1.01M | 0 |
| Dec 16, 2023↗ | WRIGHT DARA | EVP, President, CDG | Sell | 174 | $306.12 | $53.3K | 0 |
| Dec 12, 2023↗ | WRIGHT DARA | EVP, President, CDG | Sell | 1,200 | $299.16 | $359.0K | 0 |
| Nov 28, 2023↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 642 | $305.10 | $195.9K | 0 |
| Nov 1, 2023↗ | SCHWARTZ NORMAN D | Chairman, President, and CEO | Sell | 49,940 | $273.00 | $13.63M | 0 |
| Sep 1, 2023↗ | Allison Schwartz | Director | Sell | 104 | $394.60 | $41.0K | 0 |
| Sep 1, 2023↗ | COREY COLLEEN | EVP, Global Human Resources | Sell | 416 | $394.60 | $164.2K | 0 |
| Sep 1, 2023↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 500 | $394.60 | $197.3K | 0 |
| Sep 1, 2023↗ | Dahowski Diane | EVP, Global Supply Chain | Sell | 686 | $394.60 | $270.7K | 0 |
| Sep 1, 2023↗ | Daskal Ilan | EVP, Chief Financial Officer | Sell | 718 | $394.60 | $283.3K | 0 |
| Sep 1, 2023↗ | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sell | 957 | $394.60 | $377.6K | 0 |
| Sep 1, 2023↗ | Last Andrew J. | EVP, Chief Operating Officer | Sell | 1,157 | $394.60 | $456.6K | 0 |
| Sep 1, 2023↗ | MAY SIMON | EVP, President, LSG | Sell | 748 | $394.60 | $295.2K | 0 |
| Sep 1, 2023↗ | RAMALINGAM AJIT | SVP, Chief Accounting Officer | Sell | 203 | $394.60 | $80.1K | 0 |
| Sep 1, 2023↗ | WRIGHT DARA | Executive Vice President | Sell | 471 | $394.60 | $185.9K | 0 |
| Aug 30, 2023↗ | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sell | 2,350 | $395.60 | $929.7K | 0 |
| Aug 25, 2023↗ | SCHWARTZ NORMAN D | Chairman, President, and CEO | Sell | 30,385 | $381.78 | $11.60M | 0 |
| Aug 23, 2023↗ | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sell | 300 | $384.69 | $115.4K | 0 |
| Jun 15, 2023↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 500 | $379.39 | $189.7K | 0 |
| Jun 6, 2023↗ | RAMALINGAM AJIT | SVP, Chief Accounting Officer | Sell | 198 | $368.95 | $73.1K | 0 |
Showing 1–50 of 106
1 / 3
BIO Insider Buying Activity
The following table shows recent insider purchases of Bio-Rad Laboratories, Inc. (BIO) stock reported via SEC Form 4 filings.
No insider buying activity found for BIO in the last 12 months.
BIO Insider Selling Activity
The following table shows recent insider sales of Bio-Rad Laboratories, Inc. (BIO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 6, 2025↗ | BARRY JAMES | EVP, President, LSG | Sell | 700 | $306.13 | $214.3K | 0 |
| Oct 24, 2025↗ | DiVincenzo Jonathan P. | President & COO | Sell | 950 | $339.75 | $322.8K | 0 |
| Oct 20, 2025↗ | EVRAN SEDAT | EVP, Global Supply Chain | Sell | 335 | $321.90 | $107.8K | 0 |
| Sep 5, 2025↗ | Allison Schwartz | Director | Sell | 33 | $295.43 | $9.7K | 0 |
| Sep 5, 2025↗ | BARRY JAMES | EVP, President, LSG | Sell | 378 | $295.43 | $111.7K | 0 |
| Sep 5, 2025↗ | COREY COLLEEN | EVP, Global Human Resources | Sell | 209 | $295.43 | $61.7K | 0 |
| Sep 5, 2025↗ | ENGELHARDT EVA ANETTE | EVP, President, CDG | Sell | 413 | $295.43 | $122.0K | 0 |
| Sep 5, 2025↗ | ENLOE COURTNEY C | EVP, General Counsel & Sec | Sell | 275 | $295.43 | $81.2K | 0 |
| Sep 5, 2025↗ | EVRAN SEDAT | EVP, Global Supply Chain | Sell | 277 | $295.43 | $81.8K | 0 |
| Sep 5, 2025↗ | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | Sell | 550 | $295.43 | $162.5K | 0 |
| Sep 5, 2025↗ | SCHWARTZ NORMAN D | Chairman & CEO | Sell | 1,528 | $295.43 | $451.4K | 0 |
| Sep 1, 2025↗ | Allison Schwartz | Director | Sell | 55 | $297.88 | $16.4K | 0 |
| Sep 1, 2025↗ | BARRY JAMES | EVP, President, LSG | Sell | 217 | $297.88 | $64.6K | 0 |
| Sep 1, 2025↗ | COREY COLLEEN | EVP, Global Human Resources | Sell | 398 | $297.88 | $118.6K | 0 |
| Sep 1, 2025↗ | SCHWARTZ NORMAN D | Chairman & CEO | Sell | 3,084 | $297.88 | $918.7K | 0 |
| Jul 25, 2025↗ | ENGELHARDT EVA ANETTE | EVP, President, CDG | Sell | 88 | $264.19 | $23.2K | 0 |
| Apr 24, 2025↗ | ENLOE COURTNEY C | EVP, General Counsel & Sec | Sell | 67 | $249.74 | $16.7K | 0 |
| Apr 24, 2025↗ | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | Sell | 386 | $249.74 | $96.4K | 0 |
| Mar 14, 2025↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 3,000 | $247.06 | $741.2K | 0 |
| Oct 20, 2024↗ | EVRAN SEDAT | EVP, Global Supply Chain | Sell | 335 | $346.37 | $116.0K | 0 |
| Sep 6, 2024↗ | Last Andrew J. | EVP, Chief Operating Officer | Sell | 3,000 | $329.94 | $989.8K | 0 |
| Sep 1, 2024↗ | Allison Schwartz | Director | Sell | 118 | $336.63 | $39.7K | 0 |
| Sep 1, 2024↗ | BARRY JAMES | EVP, President, LSG | Sell | 1,012 | $332.89 | $336.9K | 0 |
| Sep 1, 2024↗ | COREY COLLEEN | EVP, Global Human Resources | Sell | 700 | $336.56 | $235.6K | 0 |
| Sep 1, 2024↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 1,069 | $336.52 | $359.7K | 0 |
| Sep 1, 2024↗ | Last Andrew J. | EVP, Chief Operating Officer | Sell | 1,854 | $337.32 | $625.4K | 0 |
| Sep 1, 2024↗ | SCHWARTZ NORMAN D | Chairman, President, and CEO | Sell | 5,159 | $336.60 | $1.74M | 0 |
| Jun 13, 2024↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 369 | $281.91 | $104.0K | 0 |
| Apr 29, 2024↗ | Last Andrew J. | EVP, Chief Operating Officer | Sell | 357 | $277.11 | $98.9K | 0 |
| Feb 28, 2024↗ | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sell | 2,500 | $330.55 | $826.4K | 0 |
| Feb 27, 2024↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 3,000 | $336.00 | $1.01M | 0 |
| Dec 16, 2023↗ | WRIGHT DARA | EVP, President, CDG | Sell | 174 | $306.12 | $53.3K | 0 |
| Dec 12, 2023↗ | WRIGHT DARA | EVP, President, CDG | Sell | 1,200 | $299.16 | $359.0K | 0 |
| Nov 28, 2023↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 642 | $305.10 | $195.9K | 0 |
| Nov 1, 2023↗ | SCHWARTZ NORMAN D | Chairman, President, and CEO | Sell | 49,940 | $273.00 | $13.63M | 0 |
| Sep 1, 2023↗ | Allison Schwartz | Director | Sell | 104 | $394.60 | $41.0K | 0 |
| Sep 1, 2023↗ | COREY COLLEEN | EVP, Global Human Resources | Sell | 416 | $394.60 | $164.2K | 0 |
| Sep 1, 2023↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 500 | $394.60 | $197.3K | 0 |
| Sep 1, 2023↗ | Dahowski Diane | EVP, Global Supply Chain | Sell | 686 | $394.60 | $270.7K | 0 |
| Sep 1, 2023↗ | Daskal Ilan | EVP, Chief Financial Officer | Sell | 718 | $394.60 | $283.3K | 0 |
| Sep 1, 2023↗ | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sell | 957 | $394.60 | $377.6K | 0 |
| Sep 1, 2023↗ | Last Andrew J. | EVP, Chief Operating Officer | Sell | 1,157 | $394.60 | $456.6K | 0 |
| Sep 1, 2023↗ | MAY SIMON | EVP, President, LSG | Sell | 748 | $394.60 | $295.2K | 0 |
| Sep 1, 2023↗ | RAMALINGAM AJIT | SVP, Chief Accounting Officer | Sell | 203 | $394.60 | $80.1K | 0 |
| Sep 1, 2023↗ | WRIGHT DARA | Executive Vice President | Sell | 471 | $394.60 | $185.9K | 0 |
| Aug 30, 2023↗ | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sell | 2,350 | $395.60 | $929.7K | 0 |
| Aug 25, 2023↗ | SCHWARTZ NORMAN D | Chairman, President, and CEO | Sell | 30,385 | $381.78 | $11.60M | 0 |
| Aug 23, 2023↗ | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sell | 300 | $384.69 | $115.4K | 0 |
| Jun 15, 2023↗ | Crowley Michael | EVP, GBL Commercial Operations | Sell | 500 | $379.39 | $189.7K | 0 |
| Jun 6, 2023↗ | RAMALINGAM AJIT | SVP, Chief Accounting Officer | Sell | 198 | $368.95 | $73.1K | 0 |
BIO Insiders
Similar Stocks to BIO
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
BSX
Boston Scientific Corporation
$68.91+0.51%
$101.72B
EW
Edwards Lifesciences Corporation
$81.76-3.37%
$49.14B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.20+0.77%
$18.47B
PODD
Insulet Corporation
$219.84-6.34%
$15.48B